AU3975693A - Recombinant active forms of ECEF, proteins that associate therewith, and uses thereof - Google Patents

Recombinant active forms of ECEF, proteins that associate therewith, and uses thereof

Info

Publication number
AU3975693A
AU3975693A AU39756/93A AU3975693A AU3975693A AU 3975693 A AU3975693 A AU 3975693A AU 39756/93 A AU39756/93 A AU 39756/93A AU 3975693 A AU3975693 A AU 3975693A AU 3975693 A AU3975693 A AU 3975693A
Authority
AU
Australia
Prior art keywords
ecef
proteins
active forms
recombinant active
associate therewith
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU39756/93A
Inventor
Maria Katarzyna Balcewicz-Sablinska
David S. Silberstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brigham and Womens Hospital Inc
Original Assignee
Brigham and Womens Hospital Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham and Womens Hospital Inc filed Critical Brigham and Womens Hospital Inc
Publication of AU3975693A publication Critical patent/AU3975693A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU39756/93A 1992-04-06 1993-04-06 Recombinant active forms of ECEF, proteins that associate therewith, and uses thereof Abandoned AU3975693A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US86283292A 1992-04-06 1992-04-06
US862832 1992-04-06
US90684292A 1992-07-06 1992-07-06
US906842 1992-07-06

Publications (1)

Publication Number Publication Date
AU3975693A true AU3975693A (en) 1993-11-08

Family

ID=27127723

Family Applications (1)

Application Number Title Priority Date Filing Date
AU39756/93A Abandoned AU3975693A (en) 1992-04-06 1993-04-06 Recombinant active forms of ECEF, proteins that associate therewith, and uses thereof

Country Status (2)

Country Link
AU (1) AU3975693A (en)
WO (1) WO1993020107A1 (en)

Also Published As

Publication number Publication date
WO1993020107A1 (en) 1993-10-14

Similar Documents

Publication Publication Date Title
AU4443893A (en) Peptides capable of inhibiting the activity of HIV protease, their preparation and their use
AU4403689A (en) Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
AU7516694A (en) Biotinylation of proteins
AU9156291A (en) Polypeptide analogs of apolipoprotein e, diagnostic systems and methods using the analogs
AU7565694A (en) Methods and compositions for the large scale production of recombinant adeno-associated virus
TR199501669A1 (en) Aerosol formulations of peptide and proteins.
AU5283793A (en) Recombinant specific binding protein
AU4597596A (en) Prevention of protein aggregation
AU3408289A (en) Recombinant dna expression vectors and dna compounds that encode deacetoxycephalosporin c synthetase
AU6523194A (en) Compositions including heme-containing proteins and methods relating thereto
AU3321595A (en) Recombinant production of biologically active peptides and proteins
AU4840293A (en) Cloning and expression of pur protein
AU5131493A (en) Improved semiconductor architecture and application therefor
AU6311696A (en) Recombinant protein having bacteriophage endosialidase enzymatic activity
AU6428890A (en) Therapeutic peptides and proteins
FR2694296B1 (en) Peptides inhibiting the activity of ras proteins, preparation and use.
AU633294B2 (en) Motilin-like polypeptide and use thereof
AU2670495A (en) Ifn-beta liquid formulations
AU4977796A (en) Modified lysine or arginine containing proteins and peptides
AU7635887A (en) Recombinant HTLV-III proteins and uses thereof
AU5847194A (en) Novel entomopoxvirus genes, proteins and methods of use thereof
AU1435695A (en) Recombinant human thymopoietin proteins and uses therefor
AU1405995A (en) Proteases from streptomyces and use thereof in protein expression systems
AU8769791A (en) Pharmaceutically active proteins comprising an active protein and an integrinaffinity sequence
AU4271793A (en) Novel polypeptide